AB

Andrew Bruce

Chief Executive Officer

MediSix Therapeutics

Singapore


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
MediSix Therapeutics
Industry
research
Employees
16.0
Seniority
C suite
Annual Revenue
1100000.0
Total Funding
20000000.0
Latest Funding
Series A

Technologies

Outlook Microsoft Office 365 Google Font API Typekit WordPress.org Apache Mobile Friendly AI Render Android Flutter Python SharePoint Circle IoT Basis Node.js

Keywords

cart therapy t cell leukemia therapeutics cell therapy biotechnology research t-cell therapy car t-cells pebl technology immune cell therapies cancer treatment autoimmune diseases target antigen engineering cd7 targeting cd3 complex suppression t-cell malignancies allogeneic t-cell therapies tcr t-cells tils nkg2a inhibition pd1 blockade ctla4 inhibition tim3 suppression biotechnology genomic research synthetic biology immune evasion translational research clinical trials drug development pipeline programs immunology cd19 car fda approval stem cell therapy biopharmaceuticals medical technology innovation research & development scientific collaboration academic partnerships investor relations biomedical engineering cancer immunotherapy tumor microenvironment high-throughput screening cell surface expression target protein downregulation therapeutic antibodies immunoprofile analysis tumor-associated macrophages cell processing gmp manufacturing clinical-grade production health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans